ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.235,45
0,17%
S&P 500
5.460,48
-0,41%
Dow Jones
39.118,86
-0,12%
Euro vs US Dollar
1,07205
0,00%
Bitcoin
60.894,72
0,97%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Caribou Biosciences Inc (CRBU)

  7. Caribou Biosciences Inc (CRBU) News

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRBU
DatumZeitQuelleÜberschriftSymbolFirma
14/06/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/06/202412h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
03/06/202401h00GlobeNewswire Inc.Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
30/05/202422h01GlobeNewswire Inc.Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
07/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
07/05/202422h05GlobeNewswire Inc.Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
01/05/202422h05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
24/04/202416h00GlobeNewswire Inc.Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
15/04/202415h00GlobeNewswire Inc.Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)NASDAQ:CRBUCaribou Biosciences Inc
04/04/202422h00GlobeNewswire Inc.Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusNASDAQ:CRBUCaribou Biosciences Inc
11/03/202422h08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRBUCaribou Biosciences Inc
11/03/202421h25Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRBUCaribou Biosciences Inc
11/03/202421h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRBUCaribou Biosciences Inc
11/03/202421h05GlobeNewswire Inc.Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRBUCaribou Biosciences Inc
05/03/202422h30GlobeNewswire Inc.Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202423h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
22/02/202422h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
15/02/202422h05GlobeNewswire Inc.Caribou Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CRBUCaribou Biosciences Inc
08/02/202423h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
10/01/202422h18Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CRBUCaribou Biosciences Inc
09/01/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
09/01/202422h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRBUCaribou Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CRBU

Kürzlich von Ihnen besucht

TG
BAS
BASF
AMEX
SPY
SPDR S&P 500
TG
DTE
Deutsche Telekom
USOTC
RHHBY
Roche (QX)
TG
TUI1
Tui
AMEX
XLV
Health Care Select Sector
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
USOTC
DTEGY
Deutsche Telekom (QX)
NASDAQ
TSLA
Tesla
AMEX
XLE
Energy Select Sector SPDR
AMEX
XLF
Financial Select Sector
CCOM
SILVER
SILVER
TG
MBG
MercedesBenz
NYSE
NKE
Nike
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten